RxDoctor Payments Data

Kendall Bolte, PA

Physician Assistant · York, NENPI 1215348388

Payments from drug & device makers

$1,533in general payments, 2019–2025

Across 88 payments — averaging $17.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$696
  • Novo Nordisk$183
  • Exact Sciences$122
  • Lilly USA, LLC$75
  • Astellas Pharma US Inc$69
  • Bayer$56
  • plus $332 from 16 others

What the payments were for

  • Food & beverage$1,533100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,533 in reported general payments places this provider in the 75th percentile of 1,127 physician assistant providers in Nebraska.

See all physician assistant providers in Nebraska

Medicare billing

Part B allowed, 2024
$40,594
Medicare patients
198
Services billed
1,223

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AbrysvoRsv Vacc, Pref A And Pref B/Pf74$23,681
OzempicSemaglutide16$15,231
JardianceEmpagliflozin17$13,255
MounjaroTirzepatide13$12,558
EliquisApixaban13$9,365
Tresiba Flextouch U-100Insulin Degludec15$7,583
NamzaricMemantine Hcl/Donepezil Hcl18$5,304
MyrbetriqMirabegron11$4,915
ShingrixVaricella-Zoster Ge/As01b/Pf12$2,626
Adacel TdapDiph,pertuss(Acell),tet Vac/Pf18$1,261
Omeprazole77$1,004
Doxycycline Hyclate31$887
Levothyroxine Sodium99$877
Atorvastatin Calcium97$784
Lisinopril115$739

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerAbrysvo, Eliquis$28$33,04687 claims
Novo NordiskOzempic$183$15,23116 claims
Lilly USA, LLCMounjaro$75$12,55813 claims
AbbVieNamzaric$696$5,30418 claims
Astellas Pharma US IncMyrbetriq$69$4,91511 claims
GSKShingrix$14$2,62612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,127 physician assistant providers in Nebraska.

Other physician assistant in York

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →